More medicines could be switched from prescription-only medicines (POM) to pharmacy medicines (P), as the Medicines and Healthcare Products Regulatory Agency (MHRA) has encouraged medicines manufacturers to apply for product reclassification.
Specifically, it has asked for applications regarding medicines that treat short-term sleep issues, allergies, pain, skin problems, digestive disorders, women's health and oral health.
These categories were identified as areas where more over-the-counter (OTC) medicines could be beneficial for patients, the MHRA said.
Related Article: Anticoagulant Inhixa recalled due to typo
The conditions and medicine categories were chosen by the ‘Reclassification Alliance’, led by the MHRA and OTC manufacturer representative group PAGB.
The group involves representatives from the government, NHS, clinicians, pharmacists, and industry.
The list was also scrutinised by chief pharmacists, the MHRA said.
It added that moving more medicines from POM to P would give pharmacists the tools they need to support patients in self-care for common conditions, as well as give patients greater access to medicines without the need to visit their GP.
Related Article: Interview: Pharmacy First saves time, prevents escalation, and frees up capacity
The Royal Pharmaceutical Society (RPS) has welcomed the news.
RPS president Professor Claire Anderson said enabling POM to P switches 'ensures the public get the treatment they need from community pharmacies', and reduces demand on GPs and A&E.
'Diagnosing and discussing health problems with patients and advising on the benefits and risks of treatment options are integral to the role of the pharmacy team,' she added.
Related Article: New GPhC chief standards officer appointed
And she said the RPS would 'work closely with the MHRA and manufacturers to provide guidance ensuring what is provided to the public continues to be safe and appropriate for their condition'.
A 2023 report by Frontier Economics, commissioned by PAGB, suggested that switching more medicines from POM to P could save the NHS £1.4bn a year.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.